Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

When organizations prioritize a clear purpose over profit, they have a positive influence on consumers and stakeholders of ...

Jumbo phages utilize a complex protein import system, with Imp1 as a key gatekeeper, to transport proteins into their ...

Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business and management experts.